Gary J Nabel

Washington, DC, United States of America

Gary J Nabel

Average Co-Inventor Count = 3.8

ph-index = 20

Forward Citations = 4,082(Granted Patents)

Forward Citations (Not Self Cited) = 3,321(Sep 21, 2024)

DiyaCoin DiyaCoin 8.13 

Inventors with similar research interests:


Location History:

  • Newton, MA (US) (1988)
  • Ann Arbor, MI (US) (1994 - 2007)
  • Bethesda, MD (US) (2019)
  • Cambridge, MA (US) (1985 - 2024)
  • Washington, DC (US) (2001 - 2024)
  • Chestnut Hill, MA (US) (2018 - 2024)
  • Bridgewater, NJ (US) (2021 - 2024)


Years Active: 1985-2025

where 'Filed Patents' based on already Granted Patents

107 patents (USPTO):
7 patents (CIPO):

Certainly! Here is an article about inventor Gary J Nabel:

Title: Innovator Spotlight: Gary J Nabel - Pioneering Vaccines and Ferritin Proteins

Introduction:

Gary J Nabel, a distinguished inventor, has made significant contributions in the field of vaccines and protein technology. With an impressive portfolio of 96 patents, Nabel's work has revolutionized preventative medicine. Based in Washington, DC, Nabel's innovative spirit and dedication to scientific advancement have led to groundbreaking discoveries.

Latest Patents:

1. Chimpanzee adenoviral vector-based filovirus vaccines: Nabel's invention provides vaccines that induce an immune response and protect against filovirus infections in humans. By using chimpanzee adenoviral vectors expressing filovirus proteins, the vaccine offers protection against strains of Ebolavirus and Marburg virus.

2. Ferritin proteins: Nabel's ferritin proteins, comprising mutations and immune-stimulatory moieties, have opened new possibilities in eliciting antibodies and developing antigenic responses against various pathogens.

Career Highlights:

Nabel has notably collaborated with esteemed institutions such as the University of Michigan and The United States of America, represented by the Department of Health and Human Services. His work reflects a dedication to public health and a commitment to advancing medical science for the betterment of society.

Collaborations:

Throughout his career, Nabel has collaborated with accomplished professionals such as Zhi-yong Yang and Elizabeth G Nabel. These collaborations have played a vital role in advancing his research and bringing innovative solutions to fruition.

Conclusion:

In conclusion, Gary J Nabel stands as a beacon of innovation in the field of vaccines and protein technology. His patents reflect a commitment to excellence, and his collaborations have enriched the scientific community. Nabel's contributions have not only shaped the landscape of preventative medicine but also paved the way for future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…